Stock listing

Copenhagen:PEG Pharma Equity Group A/S Aktie

Home listing (Copenhagen) of Pharma Equity Group A/S

Follow Pharma Equity Group A/S into a list and get an email when it puts out news.

Share price · OMXCOP:PEG

0.075 DKK +0.002 (+3.3%)

Close on Nov 20, 2026

Past year -36.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
0.072 – 0.075 DKKNov 20, 2026
Volume
107,662 sharesNov 20, 2026
Market cap
91.82M DKKAt the close on Nov 20, 2026 · price × 1.23B shares outstanding
52-week range
0.060 – 0.120 DKKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
34,671 DKKMedian day 231,822 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Pharma Equity Group A/S logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Copenhagen:PEG · Home0.075 DKK+0.002 (+3.3%)107,6620.0720.0750.0720.072Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXCOP:PEG · DKK, adjusted for splits

DayCloseChange%OpenHighLowVolume
0.075+0.002+3.3%0.0720.0750.072107,662
0.072-0.003-4.0%0.0730.0780.072159,004
0.075-0.001-0.8%0.0720.0750.07219,953
0.076+0.003+4.7%0.0720.0790.072238,820
0.0730.0000.0%0.0720.0790.072323,272
0.073-0.007-9.0%0.0800.0800.072570,809
0.080+0.000+0.3%0.0800.0800.072276,099
0.080+0.010+13.7%0.0850.0850.079642,693
0.070-0.006-7.7%0.0760.0760.06834,040
0.076+0.006+8.3%0.0760.0760.070240,141
0.070-0.001-1.1%0.0700.0700.06930,600
0.071+0.003+3.8%0.0680.0710.068482,860
0.068-0.007-9.1%0.0700.0700.0662,618,958
0.075-0.003-3.8%0.0780.0830.075595,286
0.078-0.004-5.1%0.0790.0820.077624,164
0.0820.000-0.2%0.0850.0850.0791,459,463
0.082+0.000+0.2%0.0840.0840.08244,071
0.082+0.004+5.1%0.0810.0830.0801,739,859
0.078-0.001-1.3%0.0800.0800.078415,000
0.079-0.001-1.0%0.0800.0800.07910,374
0.080+0.006+8.1%0.0720.0850.072214,304
0.0740.0000.0%0.0760.0760.074761,092
0.074-0.004-4.9%0.0820.0820.074231,822
0.078+0.007+10.5%0.0850.0850.075303,792
0.070-0.009-11.1%0.0780.0780.07010,000
0.079+0.002+2.3%0.0800.0800.064947,090
0.077+0.003+4.0%0.0770.0770.07710,000
0.074-0.002-2.4%0.0730.0740.073141,736
0.076-0.002-2.1%0.0780.0810.076674,584
0.078+0.000+0.3%0.0780.0790.0781,643,801
0.078+0.003+3.5%0.0750.0780.07446,525
0.075-0.005-6.3%0.0750.0780.0751,302,081
0.080+0.002+2.8%0.0780.0800.07894,722
0.0780.0000.0%0.0780.0780.078295,000
0.078+0.002+2.1%0.0740.0780.074191,153
0.076+0.001+1.6%0.0770.0770.07155,563
0.075-0.005-6.3%0.0780.0780.071212,907
0.080+0.002+3.1%0.0890.0890.080279,071
0.078-0.002-3.0%0.0790.0810.078153,714
0.080+0.007+9.6%0.0800.0800.08046,450
0.073-0.002-2.1%0.0770.0810.073149,831
0.075-0.004-4.6%0.0800.0820.075819,929
0.078-0.003-3.5%0.0810.0810.07824,616
0.081-0.001-1.5%0.0780.0820.078114,851
0.082+0.003+4.1%0.0790.0820.07818,007
0.0790.0000.0%0.0800.0850.079435,737
0.079-0.001-1.3%0.0790.0880.07926,471
0.080-0.001-1.2%0.0800.0800.079312,685
0.0810.0000.0%0.0820.0900.08134,670
0.081-0.001-1.5%0.0810.0810.08167,270
0.082+0.001+0.7%0.0820.0900.082632,622
0.082-0.003-4.0%0.0840.0840.08081,798
0.085+0.002+2.7%0.0850.0890.08545,216
0.0830.0000.0%0.0840.0860.083159,045
0.083+0.005+6.2%0.0800.0830.077341,967
0.078-0.006-7.6%0.0800.0820.0771,338,226
0.084-0.004-4.1%0.0850.0850.082618,586
0.088+0.003+3.3%0.0850.0880.084283,684
0.085-0.001-1.4%0.0900.0900.085166,155
0.086-0.002-1.8%0.0880.0900.0851,782,094
0.088+0.003+3.5%0.0840.0880.0842,354,695
0.085+0.001+1.0%0.0840.0850.08431,022
0.084+0.001+1.0%0.0830.0840.08132,021
0.083+0.001+1.7%0.0850.0850.081365,973
0.082-0.002-2.1%0.0850.0850.081131,256

Splits

3 splits since 2016 · OMXCOP:PEG · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
1-for-10Consolidation
10-for-1Split
Ticker
Copenhagen:PEG
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Copenhagen
Currency
DKK

What changed lately

Latest news

All Pharma Equity Group A/S news

Pharma Equity Group A/S on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 18 in all · newest Sep 7, 2026 · oldest 2025
Decks
4 decks · latest Jun 1, 2023

Where Pharma Equity Group A/S is listed

ListingExchangeCountryCurrency
Copenhagen:PEG · Home listing · This pageCopenhagenDenmarkDKK
Aquis:PEGCAquisUnited KingdomDKK
Aquis:PEGCAquisUnited KingdomDKK
LSE:0REULSEUnited KingdomDKK
Turquoise:PEGCTurquoiseUnited KingdomDKK

Valuation

Price/book 3.6× against a median of 0.9×: 6th lowest of 10 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
102.5M DKK
P/E
Loss
EV/sales
No revenue
EV/EBITDA
52.7×
Price/book
3.6×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.4×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Pharma Equity Group A/S Class A · OMXCOP:PEGUS$13.47MUS$15.05Mn/an/a52.7×3.6×n/a0.4×n/a
TaiwanJ Pharmaceuticals Co., Ltd. · TPEX:6549US$13.69MUS$11.86Mn/an/an/a7.0×n/a0.0×n/a
Actuate Therapeutics, Inc. · NASDAQ:ACTUUS$13.60MUS$11.50Mn/an/an/an/an/an/a1.75
BeyondSpring, Inc. · NASDAQ:BYSIUS$13.57MUS$12.99M0.3×n/an/a0.9×n/a0.0×1.31
Acumen Pharmaceuticals, Inc. · NASDAQ:ABOSUS$13.49M−US$38.84Mn/an/an/a0.4×n/a0.8×1.45
BioInvent International AB · OMXSTO:BINVUS$13.45M−US$6.62Mn/a−1.7×n/a0.7×n/a0.1×n/a
Thalia Therapeutics PLC · LSE:THATUS$13.36MUS$11.39Mn/a1,199×n/a4.2×n/a0.0×n/a
Celyad Oncology SA · EURONEXT:CYADUS$13.31MUS$13.21M14.6×573×n/a9.7×n/a0.0×n/a
Defence Therapeutics Inc Class A · CSE:DTCUS$13.27MUS$13.16Mn/an/an/a5.4×n/a0.5×0.74
Tvardi Therapeutics, Inc. · NASDAQ:TVRDUS$13.22M−US$9.05Mn/an/an/a0.9×n/a0.0×1.89
Diamyd Medical AB Class B · OMXSTO:DMYD_BUS$13.22M−US$16.66Mn/a−357×n/a0.6×n/a0.0×n/a
Median of the othersUS$13.40MUS$11.45M7.5×286×0.9×0.0×1.45

Team and board

Officers

OfficerRole
Christian TangeChief Executive Officer
Lars Otto UttenthalChief Medical Officer – Reponex Pharmaceuticals
Peter EkmanFinancial Manager

Board

DirectorRole
Charlotte PahlBoard Member
Christian VindingBoard Director
Lars GundorphBoard Member
Omar S. QandeelBoard Member

Events

QuarterResultsShare move
Q1 2025Mar 20, 2025 · Before open+1.1%
Q4 2024Nov 15, 2024 · Before open−3.1%
Q3 2024Aug 16, 2024 · Before open−3.0%
Q2 2024May 16, 2024+4.1%
Q1 2024Mar 29, 2024−7.2%
Q4 2023Nov 16, 2023+6.8%
Q3 2023Aug 16, 2023−7.7%
Q2 2023May 11, 20230.0%
Q1 2023Mar 31, 2023+5.8%
Q4 2022Nov 4, 2022+2.6%
All 16 quarters
QuarterResultsShare move
Q3 2022Aug 22, 2022−2.7%
Quarter to Mar 31, 2022Apr 1, 2022−8.8%
Quarter to Sep 30, 2021Nov 5, 2021+18.4%
Q3 2021Aug 20, 2021−3.5%
Quarter to Mar 31, 2021May 13, 2021−4.4%
Q1 2021Mar 26, 20210.0%

Open Events

Decks

DeckKindSlidesDate
H1 2023 Earnings PresentationEarnings13 slidesJun 1, 2023
Investor Presentation (March 2023)Investor deck16 slidesMar 6, 2023
Investor Presentation (March 2023)Investor deck28 slidesMar 1, 2023
Reponex Pharmaceuticals — Merger or Acquisition (February 2023)Merger or acquisition17 slidesFeb 10, 2023

Open Decks

Financings

RaiseDateIn US dollars
Convertible loans
Announced: up to DKK 8.8M
Use of proceeds: Repay existing convertible loans (DKK 600,000 and DKK 2,000,000 nominal) and a utilized credit facility of DKK 4,347,500
Dec 1, 2025US$1.37M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in DKK

Income statement

LineFY2025FY2025FY2024FY2024FY2023FY2023FY2022FY2021FY2020FY2019
Revenue00000000
Cost of revenue0311.0K0235.0K0480.0K0
Gross profit0-311.0K0-235.0K0-480.0K0
Research and development5.12M5.12M9.00M9.00M8.82M8.82M5.50K
Selling, general and administrative12.1M12.3M11.8K1.98M1.44M2.13M1.67M
Operating income-17.2M-25.3M-21.3M-21.3M-20.6M-25.3M3.03M-1.44M-17.6M-1.67M
Depreciation and amortization311.0K311.0K235.0K235.0K218.0K480.0K539236.6K206.3K171.9K
EBITDA-16.9M-25.0M-21.1M-21.1M-20.4M-24.8M3.03M-1.21M-17.4M-1.50M
Interest expense2.65M2.65M4.96M4.96M1.56M1.56M996.0K665.0K272.0K30.0K
Income before tax-26.4M-26.4M-42.4M-26.2M-26.6M-26.8M3.48M5.39M-32.9M-14.4M
Income tax-1.03M-1.03M-1.81M-1.81M-2.23M-2.23M-7.30M-6.35M15.5M5.55M
Net income-25.4M-25.4M-40.6M-24.4M-24.3M-24.6M3.48M5.39M-32.9M-14.4M
Earnings per share, basic-0.02-0.02-2.00-0.02-0.02-0.020.080.10-1.03-0.07
Earnings per share, diluted-0.02-2.00-0.02

Balance sheet

LineFY2025FY2025FY2024FY2024FY2023FY2023FY2022FY2021FY2020FY2019
Cash and equivalents498.0K498.0K4.23M1.54M4.23M4.23M182.0K01.00K
Receivables37.2M60.3M4.58M70.9M145.0K82.0K2.10M
Inventory1.00K1.59K71.3M
Current assets38.3M38.3M49.1M65.3M67.2M67.2M71.1M145.0K82.0K79.1M
Property, plant and equipment037.0K55.0K
Total assets38.9M38.9M49.4M65.6M67.7M67.7M71.1M63.6M57.6M80.8M
Accounts payable3.85M4.08M10.2M2.19M654.0K3.26M3.45M
Current liabilities8.83M8.83M8.63M8.63M34.3M34.3M25.0M14.5M23.3M5.24M
Long-term debt4.18M8.10M7.84M06.58M
Total debt8.05M11.0M30.2M22.8M18.9M10.0M1.66M
Total liabilities13.4M13.4M16.7M16.7M42.4M42.4M25.0M21.1M23.3M13.7M
Shareholders' equity25.5M25.5M32.7M48.9M25.3M25.3M46.0M42.6M34.3M67.2M
Shares outstanding1.23B1.07B1.08B44.4M55.6M31.8M203.8M

Cash flow

LineFY2025FY2025FY2024FY2024FY2023FY2023FY2022FY2021FY2020FY2019
Cash from operations-17.7M-17.7M-22.9M-22.9M-16.6M-16.6M-2.87M-2.09M-9.90M-274.0K
Capital spending-11.0K-17.7M00-73.0K-73.0K000-2.05M
Free cash flow-17.7M-17.7M-22.9M-22.9M-16.7M-16.7M-2.87M-2.09M-9.90M-2.32M
Cash from investing-11.0K11.0K0-73.0K-73.0K1.65M
Cash from financing23.1M13.9M22.9M22.9M17.1M17.1M3.06M2.09M9.90M-1.38M
Dividends paid000
Change in cash-3.73M-3.74M3.00K3.00K363.0K1.40M182.0K0

Open Financials

Cap table

Built by 6ix from Pharma Equity Group A/S Class A’s releases · as of Dec 1, 2025

Common shares
1,227,541,937
Fully diluted
1,227,541,937

Fully diluted

LineShares
Common shares1,227,541,937

Share count over time

CountShares
Nov 22, 20261,227,541,937

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charlotte PahlBoard Member · Since at least Apr 17, 2026
Christian TangeChief Executive Officer · Since at least May 11, 2026
Christian VindingBoard Director · Since at least May 11, 2026
Lars GundorphBoard Member · Since at least Apr 17, 2026
Lars Otto UttenthalChief Medical Officer – Reponex Pharmaceuticals · Since at least Nov 5, 2026
Omar S. QandeelBoard Member · Since at least Apr 17, 2026
Peter EkmanFinancial Manager · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Pharma Equity Group A/S.